Found in transcription: Accurate Parkinson's disease classification in peripheral blood

Journal of Parkinson's Disease

Volumn 3, Issue 1, 2013, Pages 19-29

  Karlsson, Magdalena Kauczynska ^a,b   Sharma, Praveen ^a   Aasly, Jan ^c   Toft, Mathias ^d   Skogar, Örjan ^e   Sæbø, Solve ^b   Lönneborg, Anders ^a  

^a DiaGenic ASA   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

biomarker; blood; classification; gene expression; Parkinson's disease

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION; UBIQUITINATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PARKINSON DISEASE; RNA; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 84880207270     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-120159     Document Type: Article

References (36)

1. de LauLM,BretelerMM(2006) Epidemiology of Parkinson's disease. Lancet Neurol 5, 525-535.
2. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5), 384-386.
3. Hatano T, Kubo SI, Sato S, Hattori N (2009) Pathogenesis of familial Parkinson's disease: New insights based on monogenic forms of Parkinson's disease. Journal of Neurochemistry 111, 1075-1093.
4. Klein C, Schneider SA, Lang AE (2009) Hereditary parkinsonism: Parkinson disease look-alikes-an algorithm for clinicians to "PARK" genes and beyond. Mov Disord 24, 2042-2058.
5. Vilariño-G̈uell C, Wider C, Ross OA, D̈achsel JA, Lincoln SJ, Kachergus JM, Soto-Ortolaza AI, Cobb SA,Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, Hentati F, Krygowska-Wajs A, Lynch T, Melamed E, Rajput A, Rajput AH, Solida A, Wu RM, Uitti RJ, Wszolek ZK, Vingerhoets F, Farrer MJ (2011) VPS35 mutations in Parkinson disease. Am J Hum Genet 89(1), 162-167.
6. Chartier-Harlin MC, Dachsel JC, Vilariño-G̈uell C, Lincoln SJ, Lepr̂etre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Melrose HL, Behrouz B,Keeling BH, Bacon JA, Hentati E,Williams L,Yanagiya A, Sonenberg N, Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska-Wajs A, Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Dest́ee A, and Farrer MJ (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet, 89(3), 398-406.
7. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. PNAS 104, 955-960.
8. Gr̈unblatt E, Zehetmayer S, Jacob CP, M̈uller T, Jost WH, Riederer P (2010) Pilot study: Peripheral biomarkers for diagnosing sporadic Parkinson's disease. J Neural Transm 117(12), 1387-1393.
9. Aguiar PMC, Severino P (2010) Biomarkers in Parkinson disease: Global gene expression analysis in peripheral blood from patients with and without mutations in PARK2 and PARK8. Einstein 8, 293-297.
10. Shehadeh LA, Yu, K, Wang L, Guevara A, Singer C, Vance J, Papapetropoulos S (2010) SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 5(2), e9104.
11. Soreq L, Israel Z, Bergman H, Soreq H (2008) Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients. J Neuroimmunol 201-202, 227-236.
12. Mutez E, Larvor L, Lepr̂etre F, Mouroux V, Hamalek D, Kerckaert JP, Ṕerez-Tur J, Waucquier N, Vanbesien-Mailliot C, Duflot A, Devos D, Defebvre L, Kreisler A, Frigard B, Dest́ee A, Chartier-Harlin MC (2011) Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiol Aging 32(10), 1839-1848.
13. Molochnikov L, Rabey JM, Dobronevsky E, Bonucelli U, Ceravolo R, Frosini D, Gr̈unblatt E, Riederer P, Jacob C, Aharon-Peretz J, Bashenko Y, Youdim MBH, Mandel SA (2012) A molecular signature in blood identifies early Parkinson's disease. Molecular Neurodegeneratio 7, 26.
14. Booij BB, Lindahl T,Wetterberg P, SkaaneNV, Sæbø S, Feten G, Rye PD, Kristiansen LI, Hagen N, Jensen M, Bardsen K, Winblad B, Sharma P, L̈onneborgA(2011)Agene expression pattern in blood for the early detection of Alzheimer's disease. J Alzheimers Dis 23(1), 109-119.
15. Rye PD, Booij BB, Grave G, Lindahl T, Kristiansen L, Andersen HM, Horndalsveen PO, Nygaard HA, Naik M, Hoprekstad D, Wetterberg P, Nilsson C, Aarsland D, Sharma P, L̈onneborg A (2011) A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis 23(1), 121-129.
16. Fehlbaum-Beurdeley P, Sol O, D́esiŕe L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemaríe JC, ZhouW, Hampel H, Einstein R,VellasB(2012)Validation of AclarusDx, a Blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J Alzheimers Dis 32, 169-181.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry 55(3), 181-184.
18. Hoehn MM, Yahr MD (1967) Parkinsonism: Onset, progression and mortality. Neurology 17, 427-442.
19. Fahn S, Elton RL (1987) Members of the UPDRS Development Committee, Unified Parkinson's Disease Rating Scale. In Recent Development in Parkinson's Disease, S. Fahn, C.O. Marsden, D.B. Calne, M. Goldstein, eds., Macmillan Health Care Information, Florham Park, NJ, 153-164.
20. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations. Mov Disord 18, 738-750.
21. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
22. Hornik (2012) "The R FAQ", Version 2.15. http://cran.rproject. org/doc/FAQ/R-FAQ.html
23. DasarathyBV(1991) Nearest Neighbor (NN) Norms:NNPattern Classification Techniques, IEEE Computer Society Press, Los Alamitos, Calif.
24. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. PNAS 99(10), 6567-6572.
25. Indahl UG, Liland KH, Næs T (2009) Canonical partial least squares-a unified PLS approach to classification and regression problems. Journal of Chemometrics 23, 495-504.
26. R Development Core Team (2011) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria 2011. http://www. Rproject. org, ISBN 3-900051-07-0
27. Martens H, Næs T (1989) Multivariate calibration, Wiley, London.
28. Ingenuity Pathways Analysis software. http://www.ingenuity. com/
29. B̈ueler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Experimental Neurology 218(2), 235-246.
30. Lewis PA, Cookson MR (2011) Gene expression in Parkinson's disease brain. Brain Research Bulletin 88(4), 302-312.
31. LeWitt P (2012) Recent advances in CSF biomarkers for Parkinson's disease. Parkinsonism Relat Disord 18(1), 49-51.
32. Blesa J, Phani S, Jackson-LewisV, Przedborski S (2012) Classic and new animal models of Parkinson's disease. Journal of Biomedicine and Biotechnology 2012, Article ID 845618, pages 10.
33. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA (2006) The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. J Lab Clin Med 147(3), 126-132.
34. Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in Parkinsonism: A prospective study. Can J Neurol Sci 18(3), 275-278.
35. Jankovic J, Rajput AH, McDermott MP, Perl DP (2000) The evolution of diagnosis in early Parkinson disease. Arch Neurol 57, 369-372.
36. Wilder SP, Kaisaki PJ, Argoud K, Salhan A, Ragoussis J, Bihoreau MT, Gauguier D (2009) Comparative analysis of methods for gene transcription profiling data derived from different microarray technologies in rat and mouse models of diabetes. BMC Genomic 10, 63.